Studies on Pol III-Associated Leukodystrophy

Pol III 相关脑白质营养不良的研究

基本信息

批准号：
10076558
负责人：
Robyn Moir
金额：
$ 20.88万
依托单位：
ALBERT EINSTEIN COLLEGE OF MEDICINE
依托单位国家：
美国
项目类别：
财政年份：
2019
资助国家：
美国
起止时间：
2019-03-01 至 2021-02-28
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/10076558
关键词：
6 year old Affect Age Animals Behavior Behavioral Biogenesis Biological Models Brain Catalytic Domain Cell Differentiation process Cell physiology Cellular Stress Cerebrum Characteristics Chemicals Childhood Chronic Clinical Clinical/Radiologic Cognitive deficits DNA Polymerase I DNA Polymerase III DNA-Directed RNA Polymerase Defect Developmental Delay Disorders Diagnosis Diet Disease Disease Progression Electron Microscopy Electron Transport Complex III Endocrine Enzymes Eukaryota Exhibits Genes Genetic Genetic Models Genetic Suppression Genetic Transcription Goals Human Hypodontia Immunohistochemistry Impairment Intellectual functioning disability Knock-in Mouse Knock-out Knockout Mice Laboratories Link Magnetic Resonance Imaging Mammals Measures Missense Mutation Molecular Motor Mus Mutant Strains Mice Mutation Myelin Myopia Nerve Degeneration Neurodegenerative Disorders Neurons Nutritional Obesity Onset of illness Pathogenesis Patients Phenotype Polymerase Population Production Proliferating Protein Biosynthesis Proteins Radiology Specialty Repression Research Resistance Saccharomycetales Sensorimotor functions Severities Severity of illness Testing Therapeutic Thinness Tissues Transfer RNA Translations Untranslated RNA Work base cognitive function cognitive regression disease phenotype experimental study leukodystrophy mouse model negative affect neuropathology prevent response ribosome profiling targeted treatment therapeutic evaluation white matter

项目摘要

Project Summary Pol III-associated leukodystrophy is an autosomal recessive neurodegenerative disease linked to mutations in subunits of RNA polymerase III (Pol III). The clinical and radiologic spectrum of the disorder has only recently been defined. Pol III-associated leukodystrophy is characterized by hypomyelination of cerebral white matter and presents as a progressive decline in motor function, developmental delay and intellectual disability. Disease onset typically occurs during childhood but the age range at diagnosis is broad, reflecting the variable severity and slow progression of the disease. Other clinical characteristics include myopia, hypodontia and endocrine abnormalities but these features are not always present. The mechanism of pathogenesis is unknown and no therapeutic options are available. Further progress in understanding this disease is limited by the lack of model systems. Thus, the goal of this research is to develop a mouse model of Pol III-associated leukodystrophy. We have created a knock-in mouse expressing clinically-defined Pol III-associated leukodystrophy mutations. We will characterize the behavioral, radiologic and neuropathologic phenotypes of these mice. Phenotypic changes will be correlated with the impact of the mutation on Pol III transcription, tRNA biogenesis and protein synthesis. In addition, we will test a model for genetic suppression of Pol III-associated leukodystrophy phenotypes. These studies will significantly enhance understanding of the pathogenesis of Pol III-associated leukodystrophy and will provide a model system for testing therapeutic approaches targeting the disease.

项目概要 Pol III 相关脑白质营养不良是一种与突变相关的常染色体隐性神经退行性疾病 RNA 聚合酶 III (Pol III) 亚基中。该疾病的临床和放射学谱仅最近被定义。 Pol III 相关脑白质营养不良的特点是脑白质髓鞘形成不足并表现为运动功能进行性衰退、发育迟缓和智力障碍。疾病发作通常发生在儿童时期，但诊断时的年龄范围很广，反映了变量疾病的严重程度和进展缓慢。其他临床特征包括近视、牙齿发育不全和内分泌异常，但这些特征并不总是存在。发病机制是未知且没有可用的治疗选择。对这种疾病的进一步了解受到以下因素的限制缺乏模型系统。因此，本研究的目标是开发 Pol III 相关的小鼠模型脑白质营养不良。我们已经创建了表达临床定义的 Pol III 相关的敲入小鼠脑白质营养不良突变。我们将表征行为、放射学和神经病理学表型这些老鼠。表型变化将与突变对 Pol III 转录、tRNA 的影响相关生物发生和蛋白质合成。此外，我们将测试 Pol III 相关基因抑制的模型脑白质营养不良表型。这些研究将显着增强对 Pol 发病机制的了解 III 相关脑白质营养不良，并将提供一个模型系统来测试针对疾病。